Safety and preliminary activity data from a single center phase II study of triplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [trident] in patients (Pts) with BRAF-mutated metastatic melanoma (MM).-Reference-Cited by-同舟云学术

Safety and preliminary activity data from a single center phase II study of triplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [trident] in patients (Pts) with BRAF-mutated metastatic melanoma (MM).

Published:2018-05-20 Issue:15_suppl Volume:36 Page:9560-9560
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Tawbi Hussein Abdul-Hassan¹,Amaria Rodabe Navroze¹,Glitza Isabella Claudia¹,Milton Denai¹,Hwu Wen-Jen²,Patel Sapna Pradyuman¹,Wong Michael K.K.²,Yee Cassian¹,Woodman Scott Eric¹,McQuade Jennifer Leigh¹,Hwu Patrick¹,Perdon Karen Mae¹,Shephard Michael²,Burton Elizabeth M.¹,Wargo Jennifer Ann¹,Davies Michael A.¹

Affiliation:

1. The University of Texas MD Anderson Cancer Center, Houston, TX;

2. University of Texas MD Anderson Cancer Center, Houston, TX;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2018.36.15_suppl.9560

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and Therapeutic Particularities of Symptomatic Melanoma Brain Metastases from Case Report to Literature Review;Diagnostics;2024-03-25

2. T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression;Cancers;2024-01-31

3. Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?;Cancer and Metastasis Reviews;2023-04-06

4. Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma;Current Oncology;2022-03-01

5. Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy;Frontiers in Oncology;2021-06-10